What does AHF stand for?

According to the FDA-approved PI, Kogenate FS is a dried concentrate preparation of antihemophilic factor produced by baby hamster kidney cells into which the human factor VIII gene has been introduced.

Food and Drug Administration to manufacture recombinant antihemophilic factor at its new Thousand Oaks facility.

Hemophilia A patients who require high doses of Helixate([R]) FS, Antihemophilic Factor (Recombinant), can now benefit from greater convenience in administering their treatment, thanks to a new 3000 IU (international unit) dosage strength.

Exclusive sponsorship of the WFH International Hemophilia Nursing Fellowship Program is one example of the many ways Bayer BP, through its Kogenate(R) line of products (Kogenate(R) FS/KOGENATE(R) Bayer, Antihemophilic Factor (Recombinant), Formulated with Sucrose), leads the industry in investing in the hemophilia community.

About Kogenate(R) FS/ KOGENATE(R) Bayer Kogenate(R) FS/KOGENATE(R) Bayer Antihemophilic Factor (Recombinant), Formulated with Sucrose, is a recombinant factor VIII treatment for hemophilia A that offers a more convenient administration by utilizing a 2.

The product inventory donation, which included Monoclate-P(R), Antihemophilic Factor (Human), Factor VIII: C Pasteurized Monoclonal Antibody Purified; Mononine(R), Coagulation Factor IX (Human), Monoclonal Antibody Purified; and Helixate(R) FS, Antihemophilic Factor (Recombinant), is part of ZLB Behring's continuing commitment to the bleeding disorders patient community around the world.

Baxter BioScience's Thousand Oaks facility manufactures recombinant Antihemophilic Factor (rAHF), which is a clotting factor produced by recombinant DNA technology and used as a treatment for the blood disorder hemophilia.

Monarc-M, Antihemophilic Factor, (Human), Method M, Monoclonal Purified is a highly purified factor VIII concentrate indicated for prevention and control of bleeding episodes in people with hemophilia A.